NaviGate Cardiac Structures Inc today touted that the first patient to receive its Gate tricuspid valved stent through a transjugular access procedure under compassionate use protocols has reached one year post-procedure and still maintains excellent valvular function. The procedure was performed last April at the Cleveland Clinic, the Lake Forest, Calif.-based company said. At one year, […]
NaviGate Cardiac Structures Inc
NaviGate touts implantation for Gate transcath tricuspid valve replacement
NaviGate Cardiac Structures Inc. said today that earlier this month, its catheter-guided Gate valved-stent bioprosthesis became the first orthotopic valve replacement in Canada to treat severe tricuspid regurgitation. The implantation was done at the Quebec Heart and Lung Institute, lead by interventional cardiologists Dr. Josep Rodes-Cabau and Dr. Francois Dagenais. The 79-year-old male patient who […]
NaviGate touts 1st 52mm transcatheter tricuspid valve procedure
NaviGate Cardiac Structures touted this week that its Gate catheter-guided tricuspid atrioventricular valved stent was implanted six weeks ago into a patient’s transplanted heart. The patient’s transplanted heart was failing due to severe tricuspid valve insufficiency. The successful implantation at the Policlinico of the University of Padua, Italy, is the first European-based patient treated with […]
NaviGate performs 1st-in-human transcath mitral valve replacement
Emerging heart valve-focused company NaviGate Cardiac Structures said it performed the 1st-in-human implant of its catheter-guided, mitral-valved stent. The company’s transcatheter mitral valve replacement system includes 2 sets of stent wings designed to surround the valve and incorporate leaflets against the valve annulus, which open with stent self-expansion to attach to the mitral valve annulus […]